Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.
Clinical trial NCT02072330 · COMPLETED
Trial details
- NCT number
- NCT02072330
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2013-12-01
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.